Correlation Between Eupraxia Pharmaceuticals and Enlivex Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eupraxia Pharmaceuticals and Enlivex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eupraxia Pharmaceuticals and Enlivex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eupraxia Pharmaceuticals and Enlivex Therapeutics, you can compare the effects of market volatilities on Eupraxia Pharmaceuticals and Enlivex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eupraxia Pharmaceuticals with a short position of Enlivex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eupraxia Pharmaceuticals and Enlivex Therapeutics.
Diversification Opportunities for Eupraxia Pharmaceuticals and Enlivex Therapeutics
-0.25 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Eupraxia and Enlivex is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Eupraxia Pharmaceuticals and Enlivex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enlivex Therapeutics and Eupraxia Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eupraxia Pharmaceuticals are associated (or correlated) with Enlivex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enlivex Therapeutics has no effect on the direction of Eupraxia Pharmaceuticals i.e., Eupraxia Pharmaceuticals and Enlivex Therapeutics go up and down completely randomly.
Pair Corralation between Eupraxia Pharmaceuticals and Enlivex Therapeutics
Assuming the 90 days horizon Eupraxia Pharmaceuticals is expected to under-perform the Enlivex Therapeutics. But the pink sheet apears to be less risky and, when comparing its historical volatility, Eupraxia Pharmaceuticals is 1.41 times less risky than Enlivex Therapeutics. The pink sheet trades about -0.03 of its potential returns per unit of risk. The Enlivex Therapeutics is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 187.00 in Enlivex Therapeutics on August 24, 2024 and sell it today you would lose (103.00) from holding Enlivex Therapeutics or give up 55.08% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 52.4% |
| Values | Daily Returns |
Eupraxia Pharmaceuticals vs. Enlivex Therapeutics
Performance |
| Timeline |
| Eupraxia Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Enlivex Therapeutics |
Eupraxia Pharmaceuticals and Enlivex Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eupraxia Pharmaceuticals and Enlivex Therapeutics
The main advantage of trading using opposite Eupraxia Pharmaceuticals and Enlivex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eupraxia Pharmaceuticals position performs unexpectedly, Enlivex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enlivex Therapeutics will offset losses from the drop in Enlivex Therapeutics' long position.| Eupraxia Pharmaceuticals vs. Akeso, Inc | Eupraxia Pharmaceuticals vs. Ascletis Pharma | Eupraxia Pharmaceuticals vs. Avax Techs | Eupraxia Pharmaceuticals vs. Eliem Therapeutics |
| Enlivex Therapeutics vs. Pluri Inc | Enlivex Therapeutics vs. BioLineRx | Enlivex Therapeutics vs. Purple Biotech | Enlivex Therapeutics vs. Histogen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |